Most people probably have a particular image of what a self-proclaimed psychedelic drug user looks like. Whatever that may be, Rachel Hope, most likely doesn’t fit that portrait.

A “teetotaler” who didn’t drink alcohol or smoke pot, Hope was part of a small test group given MDMA.

Methylenedioxy-methamphetamine or MDMA is often mistaken for “molly” or ecstasy. The reality is, with the rise in synthetic drugs being sold as molly, there’s less than a 40 percent chance of finding MDMA in substances sold on the street under those names.

For that reason and several others, Rachel Hope, a mother of four, says she was very apprehensive about taking any sort of drug to treat her PTSD. After all, she had been prescribed every traditional type of anti-anxiety medication over the last two decades. She had been hospitalized repeatedly, seen at least a dozen therapists, and still her defensive reflexes were on such high alert, she could barely stand to leave her home. So she didn’t.

Until one day, her assistant threatened to quit if she didn’t try an alternative treatment.

“He handed me a stack of medical studies being done on PTSD,” Hope says. “I read through all of them and it was a whole lot more of the same.”